In addition, the HRS cells co-express various hematopoietic cell markers and have anomalous activation of several signaling pathways (e.g., NF-κB and JAK/STAT), attributed to the frequent mutations of key TFs and/or cellular interactions within the tumor microenvironment (TME) (194). The gene discussed is NFKB1; the disease is neoplasm.